FATE
Fate Therapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
USD2.83
+0.04 (+1.25%)
Rating:C
Company Profile
CEO
Bahram Valamehr
IPO Date
2013-10-01
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$2.85
Prev. Close
$2.79
Day Low
$2.79
Day High
$2.85
52W Low
$0.91
52W High
$3.23
Market Cap
$0.33B
Volume
1.14M